Thongprakaisang (2013) and Mesnage et al (2017) showed glyphosate stimulation of estrogen receptor (ER) in ER+ BC cell lines, but not in ER-, in a dose-dependent manner. The gene discussed is ESR1; the disease is breast cancer.